Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 55

1.

Plasma 25-hydroxyvitamin D concentration and subsequent risk of total and site specific cancers in Japanese population: large case-cohort study within Japan Public Health Center-based Prospective Study cohort.

Budhathoki S, Hidaka A, Yamaji T, Sawada N, Tanaka-Mizuno S, Kuchiba A, Charvat H, Goto A, Kojima S, Sudo N, Shimazu T, Sasazuki S, Inoue M, Tsugane S, Iwasaki M; Japan Public Health Center-based Prospective Study Group.

BMJ. 2018 Mar 7;360:k671. doi: 10.1136/bmj.k671.

2.

Circulating vitamin D concentration and risk of seven cancers: Mendelian randomisation study.

Dimitrakopoulou VI, Tsilidis KK, Haycock PC, Dimou NL, Al-Dabhani K, Martin RM, Lewis SJ, Gunter MJ, Mondul A, Shui IM, Theodoratou E, Nimptsch K, Lindström S, Albanes D, Kühn T, Key TJ, Travis RC, Vimaleswaran KS; GECCO Consortium; PRACTICAL Consortium; GAME-ON Network (CORECT, DRIVE, ELLIPSE, FOCI-OCAC, TRICL-ILCCO), Kraft P, Pierce BL, Schildkraut JM.

BMJ. 2017 Oct 31;359:j4761. doi: 10.1136/bmj.j4761.

3.

Prevalence and predictors of hypovitaminosis D among the elderly in subtropical region.

Huang CH, Huang YA, Lai YC, Sun CK.

PLoS One. 2017 Jul 31;12(7):e0181063. doi: 10.1371/journal.pone.0181063. eCollection 2017.

4.

Vitamin D levels and deficiency with different occupations: a systematic review.

Sowah D, Fan X, Dennett L, Hagtvedt R, Straube S.

BMC Public Health. 2017 Jun 22;17(1):519. doi: 10.1186/s12889-017-4436-z. Review.

5.

Vitamin D and Cancer Risk and Mortality: State of the Science, Gaps, and Challenges.

Mondul AM, Weinstein SJ, Layne TM, Albanes D.

Epidemiol Rev. 2017 Jan 1;39(1):28-48. doi: 10.1093/epirev/mxx005. Review.

6.

Total and Free Circulating Vitamin D and Vitamin D-Binding Protein in Relation to Colorectal Cancer Risk in a Prospective Study of African Americans.

Andersen SW, Shu XO, Cai Q, Khankari NK, Steinwandel MD, Jurutka PW, Blot WJ, Zheng W.

Cancer Epidemiol Biomarkers Prev. 2017 Aug;26(8):1242-1247. doi: 10.1158/1055-9965.EPI-17-0133. Epub 2017 May 8.

PMID:
28483970
7.

25-Hydroxyvitamin D Status and Risk for Colorectal Cancer and Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Epidemiological Studies.

Ekmekcioglu C, Haluza D, Kundi M.

Int J Environ Res Public Health. 2017 Jan 28;14(2). pii: E127. doi: 10.3390/ijerph14020127. Review.

8.

Decreased preoperative serum 25-Hydroxyvitamin D levels in colorectal cancer are associated with systemic inflammation and serrated morphology.

Väyrynen JP, Mutt SJ, Herzig KH, Väyrynen SA, Kantola T, Karhu T, Karttunen TJ, Klintrup K, Mäkelä J, Mäkinen MJ, Tuomisto A.

Sci Rep. 2016 Nov 7;6:36519. doi: 10.1038/srep36519.

9.

25-Hydroxyvitamin D and TSH as Risk Factors or Prognostic Markers in Thyroid Carcinoma.

Danilovic DL, Ferraz-de-Souza B, Fabri AW, Santana NO, Kulcsar MA, Cernea CR, Marui S, Hoff AO.

PLoS One. 2016 Oct 13;11(10):e0164550. doi: 10.1371/journal.pone.0164550. eCollection 2016.

10.

Environmental Impact on Intestinal Stem Cell Functions in Mucosal Homeostasis and Tumorigenesis.

Augenlicht LH.

J Cell Biochem. 2017 May;118(5):943-952. doi: 10.1002/jcb.25719. Epub 2017 Jan 11. Review.

11.

Metabolomics analysis of serum 25-hydroxy-vitamin D in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study.

Nelson SM, Panagiotou OA, Anic GM, Mondul AM, Männistö S, Weinstein SJ, Albanes D.

Int J Epidemiol. 2016 Oct;45(5):1458-1468. Epub 2016 Aug 14.

12.

Vitamin D and colorectal cancer: molecular, epidemiological and clinical evidence.

Dou R, Ng K, Giovannucci EL, Manson JE, Qian ZR, Ogino S.

Br J Nutr. 2016 May;115(9):1643-60. doi: 10.1017/S0007114516000696. Review.

13.

Modifiable risk factors for the prevention of bladder cancer: a systematic review of meta-analyses.

Al-Zalabani AH, Stewart KF, Wesselius A, Schols AM, Zeegers MP.

Eur J Epidemiol. 2016 Sep;31(9):811-51. doi: 10.1007/s10654-016-0138-6. Epub 2016 Mar 21. Review.

14.

The hallmarks of premalignant conditions: a molecular basis for cancer prevention.

Ryan BM, Faupel-Badger JM.

Semin Oncol. 2016 Feb;43(1):22-35. doi: 10.1053/j.seminoncol.2015.09.007. Epub 2015 Sep 8. Review.

15.

Vitamin D and Colorectal, Breast, and Prostate Cancers: A Review of the Epidemiological Evidence.

Jacobs ET, Kohler LN, Kunihiro AG, Jurutka PW.

J Cancer. 2016 Jan 5;7(3):232-40. doi: 10.7150/jca.13403. eCollection 2016. Review.

16.

Essential Nutrient Interactions: Does Low or Suboptimal Magnesium Status Interact with Vitamin D and/or Calcium Status?

Rosanoff A, Dai Q, Shapses SA.

Adv Nutr. 2016 Jan 15;7(1):25-43. doi: 10.3945/an.115.008631. Print 2016 Jan. Review.

17.

Vitamin D: Metabolism, Molecular Mechanism of Action, and Pleiotropic Effects.

Christakos S, Dhawan P, Verstuyf A, Verlinden L, Carmeliet G.

Physiol Rev. 2016 Jan;96(1):365-408. doi: 10.1152/physrev.00014.2015. Review.

18.

Physical activity, sedentary behavior, and vitamin D metabolites.

Hibler EA, Sardo Molmenti CL, Dai Q, Kohler LN, Warren Anderson S, Jurutka PW, Jacobs ET.

Bone. 2016 Feb;83:248-255. doi: 10.1016/j.bone.2015.11.016. Epub 2015 Nov 24.

19.

Circulating levels of vitamin D and colorectal adenoma: A case-control study and a meta-analysis.

Choi YJ, Kim YH, Cho CH, Kim SH, Lee JE.

World J Gastroenterol. 2015 Aug 7;21(29):8868-77. doi: 10.3748/wjg.v21.i29.8868. Review.

20.

Vitamin D and Cancer: Diversity, Complexity, and Still a Ways to Go.

Albanes D.

Cancer Prev Res (Phila). 2015 Aug;8(8):657-61. doi: 10.1158/1940-6207.CAPR-15-0207.

Supplemental Content

Support Center